Metraipolis › archive › dc_04cff92ff758

Therapeutic outcomes of enzalutamide-docetaxel combination versus docetaxel monotherapy in post-sequential androgen receptor axis-targeted therapy failure… — Europe PMC PMID:40896445

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40896445
DOI
10.3389/fonc.2025.1608786
License (as archived)
solo-consultazione
Archived
2026-11-10T14:07:25.454Z
SHA-256 of the archived text
91c00b678fb713ad5bd33239ad7702c3eb3d1749052df2ec8650a0446055396d
Stable URL of this page
https://metraipolis.com/documento/dc_04cff92ff758

How to cite

Therapeutic outcomes of enzalutamide-docetaxel combination versus docetaxel monotherapy in post-sequential androgen receptor axis-targeted therapy failure… — Europe PMC PMID:40896445 — Europe PMC (en), https://europepmc.org/article/MED/40896445 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_04cff92ff758 (Metraipolis archive dc_04cff92ff758, sha256 91c00b678fb713ad5bd33239ad7702c3eb3d1749052df2ec8650a0446055396d)
BibTeX
@misc{dc04cff92ff758,
  title = {Therapeutic outcomes of enzalutamide-docetaxel combination versus docetaxel monotherapy in post-sequential androgen receptor axis-targeted therapy failure… — Europe PMC PMID:40896445},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40896445},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_04cff92ff758; sha256 91c00b678fb713ad5bd33239ad7702c3eb3d1749052df2ec8650a0446055396d},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40896445. Agents can read the archived copy with the MCP tool read_document.